115 related articles for article (PubMed ID: 1374791)
21. Two-drug combinations of zidovudine, didanosine, and recombinant interferon-alpha A inhibit replication of zidovudine-resistant human immunodeficiency virus type 1 synergistically in vitro.
Johnson VA; Merrill DP; Videler JA; Chou TC; Byington RE; Eron JJ; D'Aquila RT; Hirsch MS
J Infect Dis; 1991 Oct; 164(4):646-55. PubMed ID: 1716649
[TBL] [Abstract][Full Text] [Related]
22. Mutagenic study of codons 74 and 215 of the human immunodeficiency virus type 1 reverse transcriptase, which are significant in nucleoside analog resistance.
Lacey SF; Larder BA
J Virol; 1994 May; 68(5):3421-4. PubMed ID: 7512165
[TBL] [Abstract][Full Text] [Related]
23. Effects of the Delta67 complex of mutations in human immunodeficiency virus type 1 reverse transcriptase on nucleoside analog excision.
Boyer PL; Imamichi T; Sarafianos SG; Arnold E; Hughes SH
J Virol; 2004 Sep; 78(18):9987-97. PubMed ID: 15331732
[TBL] [Abstract][Full Text] [Related]
24. Use of evolutionary limitations of HIV-1 multidrug resistance to optimize therapy.
Chow YK; Hirsch MS; Merrill DP; Bechtel LJ; Eron JJ; Kaplan JC; D'Aquila RT
Nature; 1993 Feb; 361(6413):650-4. PubMed ID: 7679778
[TBL] [Abstract][Full Text] [Related]
25. Persistence of azidothymidine-resistant human immunodeficiency virus type 1 RNA genotypes in posttreatment sera.
Albert J; Wahlberg J; Lundeberg J; Cox S; Sandström E; Wahren B; Uhlén M
J Virol; 1992 Sep; 66(9):5627-30. PubMed ID: 1380098
[TBL] [Abstract][Full Text] [Related]
26. Interactions of the HIV-1 reverse transcriptase 'AZT-resistant' mutant with substrates and AZT-TP.
Pokholok DK; Gudima SO; Yesipov DS; Dobrynin VN; Rechinsky VO; Kochetkov SN
FEBS Lett; 1993 Jul; 325(3):237-41. PubMed ID: 7686510
[TBL] [Abstract][Full Text] [Related]
27. Evolution of AZT resistance in HIV-1: the 41-70 intermediate that is not observed in vivo has a replication defect.
Jeeninga RE; Keulen W; Boucher C; Sanders RW; Berkhout B
Virology; 2001 May; 283(2):294-305. PubMed ID: 11336554
[TBL] [Abstract][Full Text] [Related]
28. Establishment of new transmissible and drug-sensitive human immunodeficiency virus type 1 wild types due to transmission of nucleoside analogue-resistant virus.
de Ronde A; van Dooren M; van Der Hoek L; Bouwhuis D; de Rooij E; van Gemen B; de Boer R; Goudsmit J
J Virol; 2001 Jan; 75(2):595-602. PubMed ID: 11134272
[TBL] [Abstract][Full Text] [Related]
29. Nevirapine resistance mutations of human immunodeficiency virus type 1 selected during therapy.
Richman DD; Havlir D; Corbeil J; Looney D; Ignacio C; Spector SA; Sullivan J; Cheeseman S; Barringer K; Pauletti D
J Virol; 1994 Mar; 68(3):1660-6. PubMed ID: 7509000
[TBL] [Abstract][Full Text] [Related]
30. Selection by AZT and rapid replacement in the absence of drugs of HIV type 1 resistant to multiple nucleoside analogs.
Lukashov VV; Huismans R; Jebbink MF; Danner SA; de Boer RJ; Goudsmit J
AIDS Res Hum Retroviruses; 2001 Jun; 17(9):807-18. PubMed ID: 11429122
[TBL] [Abstract][Full Text] [Related]
31. Emergence of mutant HIV reverse transcriptase conferring resistance to AZT.
Richman DD
J Enzyme Inhib; 1992; 6(1):55-64. PubMed ID: 1285303
[No Abstract] [Full Text] [Related]
32. Potential mechanism for sustained antiretroviral efficacy of AZT-3TC combination therapy.
Larder BA; Kemp SD; Harrigan PR
Science; 1995 Aug; 269(5224):696-9. PubMed ID: 7542804
[TBL] [Abstract][Full Text] [Related]
33. Selection of mutations in the connection and RNase H domains of human immunodeficiency virus type 1 reverse transcriptase that increase resistance to 3'-azido-3'-dideoxythymidine.
Brehm JH; Koontz D; Meteer JD; Pathak V; Sluis-Cremer N; Mellors JW
J Virol; 2007 Aug; 81(15):7852-9. PubMed ID: 17507476
[TBL] [Abstract][Full Text] [Related]
34. Resistance to ddI and sensitivity to AZT induced by a mutation in HIV-1 reverse transcriptase.
St Clair MH; Martin JL; Tudor-Williams G; Bach MC; Vavro CL; King DM; Kellam P; Kemp SD; Larder BA
Science; 1991 Sep; 253(5027):1557-9. PubMed ID: 1716788
[TBL] [Abstract][Full Text] [Related]
35. Role of a dipeptide insertion between codons 69 and 70 of HIV-1 reverse transcriptase in the mechanism of AZT resistance.
Mas A; Parera M; Briones C; Soriano V; Martínez MA; Domingo E; Menéndez-Arias L
EMBO J; 2000 Nov; 19(21):5752-61. PubMed ID: 11060026
[TBL] [Abstract][Full Text] [Related]
36. AZT-related mutation Lys70Arg in reverse transcriptase of human immunodeficiency virus type 1 confers decrease in susceptibility to ddATP in in vitro RT inhibition assay.
Sharma PL; Chatis PA; Dogon AL; Mayers DL; McCutchan FE; Page C; Crumpacker CS
Virology; 1996 Sep; 223(2):365-9. PubMed ID: 8806572
[TBL] [Abstract][Full Text] [Related]
37. Zidovudine treatment results in the selection of human immunodeficiency virus type 1 variants whose genotypes confer increasing levels of drug resistance.
Kellam P; Boucher CA; Tijnagel JM; Larder BA
J Gen Virol; 1994 Feb; 75 ( Pt 2)():341-51. PubMed ID: 7509370
[TBL] [Abstract][Full Text] [Related]
38. The L74V mutation in human immunodeficiency virus type 1 reverse transcriptase counteracts enhanced excision of zidovudine monophosphate associated with thymidine analog resistance mutations.
Miranda LR; Götte M; Liang F; Kuritzkes DR
Antimicrob Agents Chemother; 2005 Jul; 49(7):2648-56. PubMed ID: 15980332
[TBL] [Abstract][Full Text] [Related]
39. Multiple mutations in HIV-1 reverse transcriptase confer high-level resistance to zidovudine (AZT).
Larder BA; Kemp SD
Science; 1989 Dec; 246(4934):1155-8. PubMed ID: 2479983
[TBL] [Abstract][Full Text] [Related]
40. Effect of resistance on combination chemotherapy for human immunodeficiency virus infection.
Cox SW; Albert J; Ljungdahl-Ståhle E; Wahren B
Adv Enzyme Regul; 1993; 33():27-36. PubMed ID: 7689290
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]